Psilocybin versus SSRIs? A cure for depression [ONLINE]

by Mind Medicine Australia // An interesting question is how psychedelics differ from conventional antidepressants that also work on the serotonin system. A trial currently underway at Imperial College will investigate a 6-week escitalopram treatment arm versus two psilocybin therapy sessions for treatment of depression. Robin Carhart-Harris will report on the results of this exciting trial during … Read morePsilocybin versus SSRIs? A cure for depression [ONLINE]

What does Psilocybin-Assisted Therapy for Depression Look Like? [ONLINE]

by Portland Psychotherapy // March 12th, 2021 – What does Psilocybin-Assisted Therapy for Depression Look Like? A Clinical Case Presentation based on a Recent Clinical Trial from Johns Hopkins with Alan K. Davis, Ph.D. This talk will integrate findings from a recent controlled trial of psilocybin therapy for people diagnosed with Major Depressive Disorder with a … Read moreWhat does Psilocybin-Assisted Therapy for Depression Look Like? [ONLINE]

Endocannabinoid medicine; A gateway to psychedelic assisted psychotherapy [ONLINE]

by Mind Medicine Australia // With Dr Jamie Rickcord Join this FREE, 60-minute online webinar to gain access to insights and learn about groundbreaking treatments to chronic mental health conditions. The endocannabinoid system is essential for human homeostasis. An ancient signalling system ubiquitous in vertebrates. There is increasing evidence that ECS dysregulation results in numerous … Read moreEndocannabinoid medicine; A gateway to psychedelic assisted psychotherapy [ONLINE]

Breakthrough Therapy for Major Depressive Disorder: Psilocybin Assisted Therapy [ONLINE]

With Dr. Alan Davis (Ohio State University) Breakthrough Therapy for Major Depressive Disorder: Psilocybin Assisted Therapy Description • The primary objective of this talk is to show the short- and long-term results from a recent randomized clinical trial of psilocybin-assisted therapy in patients with major depressive disorder (MDD). • The substantial negative public health impact … Read moreBreakthrough Therapy for Major Depressive Disorder: Psilocybin Assisted Therapy [ONLINE]

Ayahuasca for Treatment-Resistant Depression: Insights From a Randomized Clinical Trial [ONLINE]

The use of ayahuasca, an indigenous brew from the Amazonian basin with psychedelic properties, has increased worldwide and its therapeutic value has been investigated. Recently, we conducted a randomized placebo-controlled trial with ayahuasca in 35 patients with treatment-resistant depression. The results suggest a significant antidepressant effect of ayahuasca with rapid onset, already one day after … Read moreAyahuasca for Treatment-Resistant Depression: Insights From a Randomized Clinical Trial [ONLINE]

2020 Psychedelic Psychotherapy Forum [ONLINE]

Now in its 5th iteration, the 2020 Psychedelic Psychotherapy Forum // Vision & Visionaries is Canada’s premiere conference, facilitating dialogue and shared learnings about psychedelic-assisted therapies and research, including the ethical, cultural, indigenous and spiritual use of plant medicines and psychedelic substances for personal and collective healing and transformation. Our forum and workshops offer continuing education credits for healthcare … Read more2020 Psychedelic Psychotherapy Forum [ONLINE]

Psychedelics as Medicine [ONLINE]

Join Greens MP Cate Faehrmann for a discussion on the emerging field of psychedelic-assisted therapy. About this Event The emerging field of psychedelic-assisted therapy is showing breakthrough results for treatment-resistant mental disorders. Psilocybin mushrooms, LSD, MDMA and Ketamine are just some of the drugs being used to successfully treat anxiety, depression, PTSD and addiction. At … Read morePsychedelics as Medicine [ONLINE]